Comprehensive approach for cost-effective risk reduction of medical equipment in developing countries / Saqr Hamood Ahmed Dhaifallah ; Supervised Amr A. Sharawi
Material type:
- منهاج شامل نحو تقليل خطر الأجهزة الطبية في الدول النامية بتكلفة أقل [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.13.03.M.Sc.2018.Sa.C (Browse shelf(Opens below)) | Not for loan | 01010110076668000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.13.03.M.Sc.2018.Sa.C (Browse shelf(Opens below)) | 76668.CD | Not for loan | 01020110076668000 |
Thesis (M.Sc.) - Cairo University - Faculty of Engineering - Department of Systems and Biomedical Engineering
This study proposed new approach for cost-effective risk reduction by developing a risk-based safety and performance test scheduling priority index of medical equipment (SPTSPIME) and a risk-based training strategy selection priority index (TSSPIME). The first phase is to determine the factors which affect the risk and to redefine some of them appropriately for applications in this study. The second phase is the risk classification enhancement by considering a new risk classification factor, describing the categories of equipment according to what is found on studied medical devices, and scoring every category to reveal real differences between the different categories in a reasonable manner. The percentage of cost reduction by the SPTSPIME model is 59.56% of total cost of safety and performance tests. This percentage will also influence the cost of other related extensive procedures of preventive maintenance. The percentage cost reduction by the TSSPIME model is 39.29% of training cost
Issued also as CD
There are no comments on this title.